<PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">39432772</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1935-5548</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Diabetes care</Title><ISOAbbreviation>Diabetes Care</ISOAbbreviation></Journal><ArticleTitle>Comment on Hsieh et al. COVID-19 Vaccination Prior to SARS-CoV-2 Infection Reduced Risk of Subsequent Diabetes Mellitus: A Real-World Investigation Using U.S. Electronic Health Records. Diabetes Care 2023;46:2193-2200.</ArticleTitle><Pagination><StartPage>e92</StartPage><EndPage>e93</EndPage><MedlinePgn>e92-e93</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2337/dc23-2455</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rathmann</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-7804-1740</Identifier><AffiliationInfo><Affiliation>Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Diabetes Research, Partner Düsseldorf, München-Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowall</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Federal Ministry of Health, the Ministry of Culture</Agency><Country /></Grant><Grant><Agency>State of North Rhine-Westphalia</Agency><Country /></Grant><Grant><Agency>Federal Ministry of Education and Research</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Diabetes Care</MedlineTA><NlmUniqueID>7805975</NlmUniqueID><ISSNLinking>0149-5992</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Diabetes Care. 47:2193.</RefSource></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Diabetes Care. 47.</RefSource></CommentsCorrections></CommentsCorrectionsList><CoiStatement><b>Duality of Interest.</b> W.R. reports the receipt of consulting fees for attending educational sessions by Novo Nordisk outside the topic of the current work. No other potential conflicts of interest relevant to this article were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>22</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>22</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>15</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39432772</ArticleId><ArticleId IdType="pmc">PMC11502523</ArticleId><ArticleId IdType="doi">10.2337/dc23-2455</ArticleId><ArticleId IdType="pii">157365</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kowall B, Kostev K, Landgraf R, et al. . Diabetes incidence before and after COVID-19 vaccination—results from the German Disease Analyzer database. Vaccine X 2023;14:100336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10290168</ArticleId><ArticleId IdType="pubmed">37448976</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong X, Lui DTW, Chung MSH, et al. . Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: a population-based cohort study. PLoS Med 2023;20:e1004274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10406181</ArticleId><ArticleId IdType="pubmed">37486927</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh TYJ, Chang R, Yong SB, Liao PL, Hung YM, Wei JC. COVID-19 vaccination prior to SARS-CoV-2 infection reduced risk of subsequent diabetes mellitus: a real-world investigation using U.S. electronic health records. Diabetes Care 2023;46:2193–2200</Citation><ArticleIdList><ArticleId IdType="pubmed">37851392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan AC, Ebinger JE, Botting P, Navarrette J, Claggett B, Cheng S. Association of COVID-19 vaccination with risk for incident diabetes after COVID-19 infection. JAMA Netw Open 2023;6:e2255965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9929690</ArticleId><ArticleId IdType="pubmed">36787145</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy MI. Painting a new picture of personalised medicine for diabetes. Diabetologia 2017;60:793–799</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6518376</ArticleId><ArticleId IdType="pubmed">28175964</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>